SGS’s N.J. facility undergoes major expansion

Tuesday, September 25, 2012 03:44 PM

SGS Life Science Services has reopened its Fairfield, N.J. facility, having just completed a major renovation that involved doubling the size of facility, investing in new, increased laboratory space, expanded client accommodation and new equipment.

The expansion enlarges the size of the facility from 15,000 to 30,000 square feet, adding completely modernized and new GMP/GLP compliant laboratories and increases ICH Zone 1-4 storage capacities. Additionally, expanded accommodation for client audits and planning sessions were implemented as part of the design. Furthermore, SGS will invest significantly on new equipment to broaden its service offering in extractables and leachables, as well as heavy metals testing.

According to John Pirro, general manager of the Fairfield site, the facility has been designed to respond to the current and future needs of a changing bio/pharmaceutical environment. He said, "This investment will provide future capacity to service the growing needs of the bio/pharmaceutical market with expanded capabilities for stability and other project work."

Anne Hays, executive vice president, SGS, said, "With outsourcing becoming an integral part of large multinational pharmaceutical companies’ strategies, we want to assure our clients that we can accommodate both their routine and complex bio/pharmaceutical analytical outsourcing needs, integrating the latest developments in regulatory compliance."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs